Search results

2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.

Examine our bioanalytical assay list, new scientific publications, webinars, podcasts, and more, covering our full-service preclinical, clinical and manufacturing solutions…

Meet Altasciences' Dr. Lynne Le Sauteur, PhD, Vice President of Laboratory Sciences.

Hallucinogens, dissociatives and other Schedule I drugs are increasingly being found to have a clinical application in a number of therapeutic areas. Recent approvals, background, and related case studies in this month's blog.